ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests an experimental pill, NKT3964, designed to break down a protein called CDK2 that helps cancer cells grow. About 150 adults with advanced or metastatic solid tumors (including ovarian, endometrial, breast, gastric, and lung cancers) that have not respo…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Apr 28, 2026 21:34 UTC
-
New pill targets hard-to-treat cancers with KRAS mutation
Disease control Recruiting nowThis study tests a new drug, LY3537982, in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The goal is to see if the drug is safe and shrinks tumors. About 540 participants with lung, colorectal, endometrial, ovarian, pancreatic, or bile du…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 28, 2026 21:34 UTC
-
Could a drug already approved for some cancers help patients with rare genetic tumor types?
Disease control Recruiting nowThis study tests atezolizumab, a drug already approved for certain cancers, in adults and children with rare cancers that have high tumor mutational burden (TMB) or microsatellite instability (MSI). About 30 participants will receive the drug to see if it shrinks tumors or stops …
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 28, 2026 13:01 UTC